Virtual reality and hypnosis for symptom alleviation before bone marrow procedure

Bone marrow aspiration biopsy (BMAB) commonly causes anxiety in patients, negatively affecting their overall procedural experience. We aimed to evaluate the efficacy of hypnosis and virtual reality (VR) compared to standard-of-care in improving concerns of patients undergoing BMAB. In this exploratory open-label randomized-controlled trial, adult patients undergoing BMAB were randomly assigned to hypnosis, VR, or control. Interventions included a 7-minute prerecorded hypnosis session or immersive VR experience immediately prior to the procedure. Patient concerns were measured using the Measure Yourself Concerns and Wellbeing (MYCAW) questionnaire at baseline (T1), post-intervention (T2), and post-procedure (T3). The primary endpoint was the effect of the interventions on the improvement of patients' concerns score in T1-T2 and T1-T3 periods. Sixty-seven patients were randomly assigned to hypnosis (n = 22), VR (n = 24), or control (n = 21). Mean age was 61 years. Baseline MYCAW score was significantly lower in the control group (3.3 ± 1.7) as compared to both the hypnosis (4.9 ± 1.2) and VR (4.3 ± 1.7) groups (p < 0.001). These scores significantly decreased immediately post-intervention in the VR group compared to control even when considering baseline MYCAW in sensitivity analysis (p = 0.003), though this effect did not persist post-procedure (p = 0.62). Younger, less comorbid and highly absorptive patients derived the largest benefit from VR (p < 0.001). Physiological variables showed no significant differences among groups but there was a non-significant trend of lower doses of sedation in the VR group (p = 0.48) and of higher doses of local anesthesia in the control group (p = 0.13). VR demonstrated an immediate beneficial effect in improving patient concerns before BMAB even after adjustment for baseline differences. These exploratory findings support integrating mind-body interventions into clinical hematology settings but should be interpreted with caution and inform future adequately powered trials.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-11-05
DOI
https://doi.org/10.1038/s41598-025-22631-w
Primary Topic
Hematological disorders and diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Virtual reality and hypnosis for symptom alleviation before bone marrow procedure

Natalia Kreiniz, Tamar Tadmor, Zahi Arnon, Ilana Levy et al.
Scientific Reports
Hematological disorders and diagnostics
article

Virtual reality and hypnosis for symptom alleviation before bone marrow procedure

Natalia Kreiniz, Tamar Tadmor, Zahi Arnon, Ilana Levy, G. Lavie, Nagam Khateeb, Ekaterina Frosinsky, Dina Libes, Maya Meiseles, Wisal Gara, Abir Azar, Igor Abras
article en

Abstract

Bone marrow aspiration biopsy (BMAB) commonly causes anxiety in patients, negatively affecting their overall procedural experience. We aimed to evaluate the efficacy of hypnosis and virtual reality (VR) compared to standard-of-care in improving concerns of patients undergoing BMAB. In this exploratory open-label randomized-controlled trial, adult patients undergoing BMAB were randomly assigned to hypnosis, VR, or control. Interventions included a 7-minute prerecorded hypnosis session or immersive VR experience immediately prior to the procedure. Patient concerns were measured using the Measure Yourself Concerns and Wellbeing (MYCAW) questionnaire at baseline (T1), post-intervention (T2), and post-procedure (T3). The primary endpoint was the effect of the interventions on the improvement of patients' concerns score in T1-T2 and T1-T3 periods. Sixty-seven patients were randomly assigned to hypnosis (n = 22), VR (n = 24), or control (n = 21). Mean age was 61 years. Baseline MYCAW score was significantly lower in the control group (3.3 ± 1.7) as compared to both the hypnosis (4.9 ± 1.2) and VR (4.3 ± 1.7) groups (p < 0.001). These scores significantly decreased immediately post-intervention in the VR group compared to control even when considering baseline MYCAW in sensitivity analysis (p = 0.003), though this effect did not persist post-procedure (p = 0.62). Younger, less comorbid and highly absorptive patients derived the largest benefit from VR (p < 0.001). Physiological variables showed no significant differences among groups but there was a non-significant trend of lower doses of sedation in the VR group (p = 0.48) and of higher doses of local anesthesia in the control group (p = 0.13). VR demonstrated an immediate beneficial effect in improving patient concerns before BMAB even after adjustment for baseline differences. These exploratory findings support integrating mind-body interventions into clinical hematology settings but should be interpreted with caution and inform future adequately powered trials.

Scientific ReportsVol. 15(1)
The Max Stern Yezreel Valley College (IL), Technion – Israel Institute of Technology (IL), Bnai Zion Medical Center (IL)
Openalex Percentile: Top 52%
Hematological disorders and diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.